Balen Abdulrahman

Coronary Research Group, University Hospital Southampton NHS Foundation Trust, Southampton, UK

  • OrcidID

Articles by Balen Abdulrahman

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?

Balen Abdulrahman, Richard J Jabbour, Nick Curzen, et al


Citation: Interventional Cardiology 2023;18:e22.